New Mexico medical board advertising rules: the 61-6-15 and 16.10.8 NMAC guide
New Mexico physician advertising falls under the Medical Practice Act, NMSA 1978 61-6-15(D), and the New Mexico Medical Board's rule at 16.10.8.8 NMAC, which lists "deceptive or anonymous advertising" and "improper use of a fictitious name" as unprofessional or dishonorable conduct. The statute adds false or misleading statements about skill or treatment efficacy, and fee splitting.
- The regulator is the New Mexico Medical Board, under the Medical Practice Act (NMSA 1978 Chapter 61, Article 6).
- 16.10.8.8 NMAC lists deceptive or anonymous advertising (I) and improper use of a fictitious name (J) as unprofessional or dishonorable conduct.
- NMSA 61-6-15(D)(9): false or misleading statements about the licensee's skill or the efficacy or value of a treatment. (D)(18): conduct likely to deceive, defraud or harm the public.
- NMSA 61-6-15(D)(16): fee splitting.
- Anonymous advertising is the distinctive New Mexico point: ads should make clear who the responsible licensed practice or physician is.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Which boards regulate New Mexico healthcare advertising
The New Mexico Medical Board licenses and disciplines physicians and physician assistants under the Medical Practice Act. Its rules are in Title 16, Chapter 10 of the New Mexico Administrative Code; Part 8 covers unprofessional or dishonorable conduct. Confirm with the Board which license category applies to osteopathic physicians in your practice.
Dentists are licensed by the New Mexico Board of Dental Health Care under separate rules.
NMSA 61-6-15(D) and 16.10.8.8 NMAC, explained
The statute: 61-6-15(D)
- (D)(9) Making false or misleading statements regarding the skill of the licensee or the efficacy or value of the medicine, treatment or remedy prescribed.
- (D)(15) Using a false, fraudulent or deceptive statement in a document connected with the practice.
- (D)(16) Fee splitting.
- (D)(18) Conduct likely to deceive, defraud or harm the public.
The rule: 16.10.8.8 NMAC
16.10.8.8 NMAC expands on the statute's catch-all for unprofessional or dishonorable conduct. Its list includes:
- (H) dishonesty;
- (I) deceptive or anonymous advertising;
- (J) improper use of a fictitious name;
- (L) prescribing, dispensing or administering drugs to a patient without an established physician-patient relationship, including over the internet, with listed exceptions such as documented telehealth encounters.
16.10.8.7 NMAC defines an established physician-patient relationship as at least an interactive encounter with an appropriate history and examination sufficient to diagnose and treat, informed consent, availability for follow-up, and a medical record.
Allowed, prohibited, needs disclosure: the New Mexico working table
How we apply New Mexico law on pre-publication reviews.
| Creative element | Status | Practical rule and basis |
|---|---|---|
| Unbranded or "lead-gen" landing pages | Prohibited in practice | Anonymous advertising is listed (16.10.8.8(I)). Identify the practice and responsible physician. |
| DBA or trade name | Needs review | Improper use of a fictitious name is listed (16.10.8.8(J)). Make sure the name is properly registered and tied to the licensed practice. |
| Efficacy claims ("works for everyone") | Needs substantiation | False or misleading statements about efficacy or value (61-6-15(D)(9)). |
| Skill or superiority claims | Needs substantiation | False or misleading statements about skill (61-6-15(D)(9)). |
| Revenue-share or per-patient marketing fees | High risk | Fee splitting is a listed ground (61-6-15(D)(16)). Get legal review. |
| "Quiz then prescription" telehealth funnels | Needs review | An established physician-patient relationship is required before prescribing (16.10.8.7, 16.10.8.8(L)). |
| Testimonials and before-and-after images | Allowed with care | Must not deceive (61-6-15(D)(18)); HIPAA authorization; FTC disclosures. |
What is different about New Mexico
No anonymous ads
New Mexico expressly names anonymous advertising as unprofessional conduct. Every ad, landing page and lead form should identify who is offering the service. This is a common gap in performance marketing, where test pages and lead-gen microsites often carry no practice name.
Fictitious names
Brand names, DBAs and campaign names are fine when used properly, but the rule targets improper use of a fictitious name. Keep a record tying every brand to the licensed entity and physician.
Telehealth and online prescribing
Ads for online weight-loss, hormone or other prescription programs should not imply a prescription will follow automatically. The Board's rule requires an established physician-patient relationship, with telehealth allowed when the encounter meets the standard.
How federal rules layer on top of New Mexico law
New Mexico board rules sit on top of a federal floor that applies to every US practice. In short:
- FTC Act and the Endorsement Guides (16 CFR Part 255). Claims need a reasonable basis before they run. Reviews, testimonials and influencer posts must reflect real experience, and any material connection (payment, free treatment, staff or family ties) must be disclosed clearly. If results shown are not what patients generally get, say what they can generally expect.
- FTC rule on consumer reviews and testimonials (16 CFR Part 465, effective October 21, 2024). Bans fake or AI-invented reviews, buying positive reviews, undisclosed insider reviews and review suppression, with civil penalties available per violation.
- HIPAA marketing rule (45 CFR 164.501 and 164.508(a)(3)). Using a patient's protected health information in marketing (a named testimonial, a before-and-after photo, a case story) generally needs the patient's signed written authorization. Replying to an online review in a way that confirms someone is a patient can be an impermissible disclosure. Tracking pixels on pages that collect health information need a careful look too. See our HIPAA-compliant healthcare marketing guide.
- TCPA (47 U.S.C. 227; 47 CFR 64.1200). Marketing texts and autodialed or prerecorded calls to mobile phones need prior express written consent. Keep the consent record and honor opt-outs.
- CAN-SPAM. Marketing email needs an accurate sender, a non-deceptive subject line, a physical address and a working unsubscribe.
Platform policies (Google Ads healthcare and medicines policy, Meta's health and wellness ad rules) are a further layer. They can reject an ad that is lawful in New Mexico, so plan creative to clear all three: state rule, federal rule, platform rule.
New Mexico compliance checklist for website, ads, social and reviews
Website and provider pages
Each page names the practice and responsible clinician. Brand names map to the licensed entity. Efficacy and skill claims are supported by evidence.
Paid search and paid social
No unbranded landing pages or lead forms. Telehealth ads describe a consultation, not a guaranteed prescription. Review vendor pay structures for fee-splitting risk.
Organic social and influencers
Disclose every material connection on the post itself (#ad or "paid partnership", plus free treatment or discounts). Get a HIPAA authorization before posting any patient image or story. Keep result claims to what patients generally achieve.
Reviews and reputation
Ask every patient the same way, never pay or discount for a review, and never gate or suppress negative ones. Reply without confirming that the reviewer is a patient or discussing their care; move details offline.
Brand-to-license register
Keep a register linking every brand, DBA, domain and campaign name to the licensed practice and responsible physician.
Substantiation file
For every factual claim (years in practice, procedure counts, certifications, "first" or "only" claims), keep a dated record of the evidence. Review the file when credentials, staff or services change.
New Mexico medical advertising: common questions
What does New Mexico say about medical advertising?
16.10.8.8 NMAC lists deceptive or anonymous advertising and improper use of a fictitious name as unprofessional or dishonorable conduct, and NMSA 61-6-15(D)(9) covers false or misleading statements about skill or treatment efficacy.
Is anonymous advertising really prohibited in New Mexico?
Yes. "Deceptive or anonymous advertising" is item I in 16.10.8.8 NMAC. Identify the practice and responsible clinician in your ads and landing pages.
Is fee splitting prohibited in New Mexico?
Yes. Fee splitting is listed in NMSA 61-6-15(D)(16) as unprofessional or dishonorable conduct.
Can a New Mexico telehealth practice advertise online prescriptions?
It can advertise consultations, but prescribing requires an established physician-patient relationship as defined in 16.10.8.7 NMAC, with telehealth exceptions when properly documented.
Which board regulates New Mexico physicians?
The New Mexico Medical Board, under the Medical Practice Act (NMSA 1978 Chapter 61, Article 6).
Sources
Official New Mexico sources first, then federal. Where an official site blocked automated access, we confirmed the text through a published copy of the same section and say so below.
- 16.10.8 NMAC, Medical Board standards incl. 16.10.8.8 (New Mexico Medical Board, PDF)
- 16.10.8.8 NMAC (Cornell LII copy)
- NMSA 1978 61-6-15, published copy used to confirm subsection text (FindLaw)
- New Mexico Medical Board
- FTC Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (eCFR)
- FTC Trade Regulation Rule on the Use of Consumer Reviews and Testimonials, 16 CFR Part 465 (eCFR)
- Final rule notice, 89 Fed. Reg. (August 22, 2024), effective October 21, 2024 (GovInfo)
- HIPAA Privacy Rule, uses and disclosures requiring authorization, 45 CFR 164.508 (eCFR)
- HIPAA Privacy Rule definitions including "marketing", 45 CFR 164.501 (eCFR)
- TCPA implementing rules, 47 CFR 64.1200 (eCFR)
Neighboring states and next reads
Get your New Mexico marketing checked before it runs
Book a call with the Ichelon Consulting US team in Dallas (Central Time). We review your website, ads and review responses against the New Mexico rules above and the federal layer, then fix what needs fixing. Every US client signs a BAA with us; our client-facing team holds HIPAA compliance training certificates. Retainers are custom-scoped, from $499/month.